nivolumab,relatlimab
bms
['neopredict', 'lung', 'nivolumab', 'nsclc', 'relatlimab', 'nivo', 'lcsm,(-blcsm)', 'sclc']
surgery for nsclc after nivolumab plus relatlimab is as safe as surgery after nivolumab alone, the neopredict-lung study suggests. #asco23 #lcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.